A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels

Blood Glucose Male population Polymorphism, Single Nucleotide Body Mass Index regulatory protein 03 medical and health sciences Meta-Analysis as Topic Insulin-Secreting Cells Insulin Secretion Humans Insulin Genetic Predisposition to Disease Alleles disease locus 0303 health sciences Fasting Introns Diabetes Mellitus, Type 2 genome-wide association Glucose-6-Phosphatase Linear Models mortality risk Female diabetes-mellitus
DOI: 10.1126/science.1156849 Publication Date: 2008-05-04T04:48:51Z
ABSTRACT
Several studies have shown that healthy individuals with fasting plasma glucose (FPG) levels at the high end of the normal range have an increased risk of mortality. To identify genetic determinants that contribute to interindividual variation in FPG, we tested 392,935 single-nucleotide polymorphisms (SNPs) in 654 normoglycemic participants for association with FPG, and we replicated the most strongly associated SNP (rs560887, P = 4 × 10 –7 ) in 9353 participants. SNP rs560887 maps to intron 3 of the G6PC2 gene, which encodes glucose-6-phosphatase catalytic subunit–related protein (also known as IGRP), a protein selectively expressed in pancreatic islets. This SNP was associated with FPG (linear regression coefficient β = –0.06 millimoles per liter per A allele, combined P = 4 × 10 –23 ) and with pancreatic β cell function (Homa-B model, combined P = 3 × 10 –13 ) in three populations; however, it was not associated with type 2 diabetes risk. We speculate that G6PC2 regulates FPG by modulating the set point for glucose-stimulated insulin secretion in pancreatic β cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (197)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....